SBBP - Strongbridge Biopharma plc

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
164.79M
Enterprise Value 3
86.72M
Trailing P/E
4.90
Forward P/E 1
-4.28
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
7.99
Price/Book (mrq)
2.07
Enterprise Value/Revenue 3
4.21
Enterprise Value/EBITDA 6
-1.29

Trading Information

Stock Price History

Beta (5Y Monthly) 5.69
52-Week Change 3-38.00%
S&P500 52-Week Change 324.65%
52 Week High 35.6900
52 Week Low 31.4300
50-Day Moving Average 32.1274
200-Day Moving Average 32.2812

Share Statistics

Avg Vol (3 month) 3496.64k
Avg Vol (10 day) 3757.11k
Shares Outstanding 554.21M
Float 28.29M
% Held by Insiders 114.49%
% Held by Institutions 167.23%
Shares Short (Dec 30, 2019) 4518.49k
Short Ratio (Dec 30, 2019) 41.33
Short % of Float (Dec 30, 2019) 41.22%
Short % of Shares Outstanding (Dec 30, 2019) 40.96%
Shares Short (prior month Nov 28, 2019) 4844.24k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin 211.37%
Operating Margin (ttm)-353.28%

Management Effectiveness

Return on Assets (ttm)-34.52%
Return on Equity (ttm)118.78%

Income Statement

Revenue (ttm)20.62M
Revenue Per Share (ttm)0.39
Quarterly Revenue Growth (yoy)6.30%
Gross Profit (ttm)14.04M
EBITDA -67.34M
Net Income Avi to Common (ttm)43.59M
Diluted EPS (ttm)0.6210
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)79.61M
Total Cash Per Share (mrq)1.47
Total Debt (mrq)1.54M
Total Debt/Equity (mrq)1.93
Current Ratio (mrq)4.24
Book Value Per Share (mrq)1.47

Cash Flow Statement

Operating Cash Flow (ttm)-75.64M
Levered Free Cash Flow (ttm)-31.84M